Dr. Gulick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5303 S Cedar St
Lansing, MI 48911Phone+1 517-887-4302Fax+1 517-887-4437
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1983 - 1984
- Cleveland Clinic FoundationFellowship, Infectious Disease, 1981 - 1983
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1980 - 1981
- Cleveland Clinic FoundationResidency, Internal Medicine, 1977 - 1980
- Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1976
Certifications & Licensure
- MI State License 1984 - 2027
- OH State License 1977 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Internal Medicine Medical Oncology
- AOA Board of Internal Medicine Infectious Disease
- AOA Board of Internal Medicine Oncology
Publications & Presentations
PubMed
- 42 citationsNeutropenia during HIV infection: adverse consequences and remedies.Xin Shi, Matthew Sims, Michel M. Hanna, Ming Xie, Peter Gulick
International Reviews of Immunology. 2014-11-11 - 26 citationsSLAMF7 Is a Critical Negative Regulator of IFN-α-Mediated CXCL10 Production in Chronic HIV Infection.Patrick O'Connell, Yuliya Pepelyayeva, Maja K Blake, Sean Hyslop, Robert B. Crawford
Journal of Immunology. 2019-01-01 - 53 citationsHIV-infected cannabis users have lower circulating CD16+ monocytes and IFN-γ-inducible protein 10 levels compared with nonusing HIV patients.Michael D. Rizzo, Robert B. Crawford, Joseph E. Henriquez, Yasser A. Aldhamen, Peter Gulick
AIDS. 2017-11-01
Journal Articles
- Interferon- Α-mediated Activation of T Cells from Healthy and HIV-Infected Individuals Is Suppressed by Δ 9 -Tetrahydrocannabinol IPeter Gulick, DO, Drug Metabolism & Disposition
Press Mentions
- Experts Say Pandemic Is ‘Not at All’ over While Grappling with Gaps in COVID-19 DataMay 9th, 2023
- A Promising New Covid Pill Shows Key Advantages over Paxlovid in TrialsDecember 29th, 2022
- Ask the Expert: COVID and the Recent Surge in CasesMay 23rd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: